SANTÉ’s Post

Pricing and Market Access (P&MA) is no longer an afterthought but a critical determinant of a product's success. Learn how to develop a robust P&MA strategy that drives both commercial success and patient outcomes in this second webinar of our Biotech growth series on "Navigating the path from innovation to market success"! This webinar is specifically geared towards smaller / mid-sized biotechs and will cover: 1) Insights into state-of-the-art P&MA decision making from start to finish and the key steps to ensure global P&MA success 2) Techniques for navigating the tradeoff between price, reimbursement, and physician uptake to optimize your revenue potential 3) Current and crucial global P&MA trends (e.g., IRA/PDAP in the US, EU JCA) and their implications for your strategy development and required skillset I look forward to seeing you on Oct 16!

Could your life sciences strategy be missing a key ingredient for success? Paul Martinetti, MD will be at the #LifeSciencesSummit on 10/8 to talk all things life sciences—and how Bracken’s agile solutions and integrated approach can help you succeed. Paul’s ready to answer your questions—let’s connect! #LifeSciencesSummit #Biotech #ConsultingServices #LifeSci #Bracken

Unlock success with a strong Pricing & Market Access (P&MA) strategy! Join expert Mark Kastner in the second Better Biotech Growth webinar to learn how P&MA drives both commercial success and patient outcomes. Discover key insights on global trends like IRA/PDAP and the EU JCA. Register now! skp.link/rqbl #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth

Biotechs have been the best group for Brian Shannon. Watch this video to find out why. For more insights, follow Brian on X at @alphatrends. #brianshannon #stockmarketInsights #biotechs

We had an exciting and insightful discussion about the critical connection between value creation and achieving the right regulatory milestones. Our panelists shared valuable strategies on how to collaborate with experts to minimize both costs and time to bring therapies to patients. A huge thank you to our amazing panelists for their time and expertise, and to our incredible sponsors and hosts—NewYorkBIO, IndieBio, and of course Voisin Consulting Life Sciences (VCLS)—for making this event possible! If you would like to learn more about the event or schedule a potential one-on-one introduction, please feel free to reach out to Sébastien Giraudier, PhD via LinkedIn. #biotech #lifesciences #regulatorystrategy #valuecreation #biotechcommunity #NYC

🚨 Happening Now! Our live webinar with California Life Sciences (CLS) is underway! Join us as industry experts dive into scaling financial operations in life sciences and biotech with fractional teams. 📢 It's not too late! Register now and catch the valuable insights in real time. https://hubs.li/Q02WgpWL0 #Webinar #LifeSciences #Biotech #FinancialManagement #FractionalTeams

In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech

In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech

In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech

Biotechs have been the best group for me. Check out this video to find out why. For more insights, follow me on X at @alphatrends. #brianshannon #stockmarketInsights #biotechs